Allogene Therapeutics, Inc.’s ALLO share price has surged by 6.64%, which has investors questioning if this is right time to ...

Piper Sandler analyst Biren Amin maintained a Buy rating on LENZ Therapeutics (LENZ – Research Report) today and set a price target of $51.00.

Piper Sandler analyst Biren Amin maintained a Buy rating on Monopar Therapeutics Inc (MNPR – Research Report) today and set a price target of ...

What is short selling? It's a high-risk strategy where investors profit from falling stock prices. Learn how it works, its ...

SEC Filings provided by EDGAR Online, Inc.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

In 2018, the former leadership of team from Kite Pharma founded Allogene, on a mission to outdo the CAR-T cancer cell therapies they had just sold to Gilead for $12 billion with an "off-the-shelf ...

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Click Therapeutics' digital therapeutic (DTx) for migraine prevention has been cleared by the FDA, becoming the first treatment of its type in the US. The importance of biosimilars only continues ...